{"output": [["Sanofi", "COMP", "Obtain", "Right", "ORG/REG"], ["Sanofi", "COMP", "Develop", "Fitusiran", "PRODUCT"], ["Sanofi", "COMP", "Sell", "Fitusiran", "PRODUCT"], ["Sanofi Genzyme", "COMP", "Global Commercialization", "Fitusiran", "PRODUCT"], ["Alnylam Pharmaceuticals", "COMP", "Royalties", "Fitusiran", "PRODUCT"], ["Sanofi Genzyme", "COMP", "Rare Hematology Portfolio", "Fitusiran", "PRODUCT"], ["Alnylam", "COMP", "Global Development", "New Treatment", "PRODUCT"], ["Alnylam", "COMP", "Global Commercialization", "New Treatment", "PRODUCT"], ["Sanofi Genzyme", "COMP", "Sustained Interest", "Alnylam\u2019s Portfolio", "PRODUCT"], ["Sanofi", "COMP", "Opt", "Other Alnylam Rare Genetic Disease Programs", "PRODUCT"], ["Sanofi", "COMP", "Global License", "One Right", "CONCEPT"], ["Sanofi", "COMP", "Reporting", "Geert De Clercq", "PERSON"], ["Sanofi", "COMP", "Editing", "Biju Dwarakanath", "PERSON"]], "published": "2018-01-08T09:02:00.000+02:00"}